Literature DB >> 826948

Increase in the power of human memory in normal man through the use of drugs.

S J Dimond, E M Brouwers.   

Abstract

Nootropyl (Piracetam) a drug reported to facilitate learning in animals was tested for its effect on man by administering it to normal volunteers. The subjects were given 3x4 capsules at 400 mg per day, in a double blind study. Each subject learned series of words presented as stimuli upon a memory drum. No effects were observed after 7 days but after 14 days verbal learning had significantly increased.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826948     DOI: 10.1007/BF00426834

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

1.  Two methods for testing serial memorization.

Authors:  N C WAUGH
Journal:  J Exp Psychol       Date:  1963-02

2.  Short-term retention of individual verbal items.

Authors:  L R PETERSON; M J PETERSON
Journal:  J Exp Psychol       Date:  1959-09

3.  The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.

Authors:  A J Stegink
Journal:  Arzneimittelforschung       Date:  1972-06

4.  The "nootropic" approach to the pharmacology of the integrative activity of the brain.

Authors:  C Giurgea
Journal:  Cond Reflex       Date:  1973 Apr-Jun

5.  Levodopa treatment of Parkinson's syndrome. Improved intellectual functioning.

Authors:  A W Loranger; H Goodell; J E Lee; F McDowell
Journal:  Arch Gen Psychiatry       Date:  1972-02
  5 in total
  12 in total

1.  A new chemotherapeutic investigation: Piracetam effects on dyslexia.

Authors:  C H Chase; R L Schmitt; G Russell; P Tallal
Journal:  Ann Dyslexia       Date:  1984-01

2.  The nootropic concept and dyslexia.

Authors:  C R Wilsher
Journal:  Ann Dyslexia       Date:  1986-01

Review 3.  Piracetam in developmental reading disorders: A review.

Authors:  Colin R Wilsher; Eric A Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-04       Impact factor: 4.785

Review 4.  Critical review of clinical trials in senile dementia--II.

Authors:  J M Orgogozo; R Spiegel
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

Review 5.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

Review 6.  Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Jie Zhang; Ruili Wei; Zhongqin Chen; Benyan Luo
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

7.  High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study.

Authors:  C Barnas; C Miller; H Ehrmann; P Schett; V Günther; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Some effects of piracetam (UCB 6215, Nootropyl) on chronic schizophrenia.

Authors:  S J Dimond; R E Scammell; I G Pryce; D Huws; C Gray
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

9.  Piracetam as an aid to learning in dyslexia. Preliminary report.

Authors:  C Wilsher; G Atkins; P Manfield
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

10.  Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment.

Authors:  G Chouinard; L Annable; A Ross-Chouinard; M Olivier; F Fontaine
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.